CRIS Current Research Information System

CUCCHETTI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.451
AS - Asia 13.039
EU - Europa 12.244
AF - Africa 1.010
SA - Sud America 958
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 7
Totale 46.730
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.291
SG - Singapore 4.394
CN - Cina 3.297
GB - Regno Unito 3.070
VN - Vietnam 2.612
DE - Germania 1.860
IT - Italia 1.721
SE - Svezia 1.332
HK - Hong Kong 1.094
NL - Olanda 1.008
IN - India 906
BR - Brasile 705
RU - Federazione Russa 700
IE - Irlanda 504
FR - Francia 472
UA - Ucraina 450
ZA - Sudafrica 278
CI - Costa d'Avorio 262
TG - Togo 243
CH - Svizzera 229
EE - Estonia 227
KR - Corea 196
FI - Finlandia 181
BG - Bulgaria 137
JP - Giappone 130
AR - Argentina 111
SC - Seychelles 102
JO - Giordania 99
CA - Canada 90
AT - Austria 80
ID - Indonesia 65
NG - Nigeria 64
EC - Ecuador 54
BE - Belgio 51
MX - Messico 47
ES - Italia 44
TR - Turchia 43
PL - Polonia 40
BD - Bangladesh 28
IR - Iran 27
HR - Croazia 24
CL - Cile 22
GR - Grecia 21
PK - Pakistan 20
AU - Australia 19
CO - Colombia 18
PY - Paraguay 17
RO - Romania 17
UZ - Uzbekistan 15
CZ - Repubblica Ceca 14
LB - Libano 14
LT - Lituania 14
PE - Perù 14
IQ - Iraq 13
MY - Malesia 13
MA - Marocco 12
PH - Filippine 11
EG - Egitto 10
ET - Etiopia 8
KZ - Kazakistan 8
SA - Arabia Saudita 8
KE - Kenya 7
PT - Portogallo 7
UY - Uruguay 7
DO - Repubblica Dominicana 6
DZ - Algeria 6
IL - Israele 6
NO - Norvegia 6
TW - Taiwan 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
DK - Danimarca 5
MK - Macedonia 5
SK - Slovacchia (Repubblica Slovacca) 5
TH - Thailandia 5
AZ - Azerbaigian 4
RS - Serbia 4
TN - Tunisia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AF - Afghanistan, Repubblica islamica di 3
BO - Bolivia 3
BZ - Belize 3
JM - Giamaica 3
LU - Lussemburgo 3
MM - Myanmar 3
MO - Macao, regione amministrativa speciale della Cina 3
AL - Albania 2
BY - Bielorussia 2
CG - Congo 2
CR - Costa Rica 2
EU - Europa 2
KH - Cambogia 2
MD - Moldavia 2
ME - Montenegro 2
NZ - Nuova Zelanda 2
PA - Panama 2
UG - Uganda 2
XK - ???statistics.table.value.countryCode.XK??? 2
YT - Mayotte 2
AM - Armenia 1
Totale 46.701
Salva come PNG Salva come JPEG
Città #
Fairfield 2.941
Singapore 2.901
Southend 2.754
Ashburn 2.007
Chandler 1.319
Woodbridge 1.208
Dong Ket 1.105
Hong Kong 1.083
Seattle 1.006
Wilmington 1.006
Houston 966
Cambridge 820
Santa Clara 723
Princeton 683
Kerkrade 651
Ann Arbor 529
Dublin 504
Beijing 495
Boardman 462
Bologna 423
Frankfurt am Main 415
Hefei 413
Ho Chi Minh City 383
Westminster 276
Nanjing 263
Abidjan 262
Los Angeles 258
Hanoi 243
Lomé 243
Dallas 242
Jacksonville 239
Padova 228
Berlin 203
Seoul 191
New York 179
Bern 174
Buffalo 149
San Diego 142
Jinan 134
Sofia 132
Saint Petersburg 130
Redondo Beach 128
Shenyang 128
Helsinki 122
Tokyo 122
Munich 121
Milan 114
Florence 106
Amman 99
Delhi 91
Redmond 90
Nanchang 84
Dearborn 83
Changsha 82
Turin 79
Guangzhou 78
São Paulo 77
Hebei 71
Chicago 69
Shanghai 67
Des Moines 60
Falls Church 58
Jiaxing 56
Abeokuta 55
Tianjin 54
Zhengzhou 54
Medford 52
Mülheim 52
Brussels 49
Norwalk 49
Bengaluru 48
Hangzhou 48
London 47
Phoenix 45
Da Nang 44
Rome 43
Falkenstein 42
Olalla 40
Turku 40
Vienna 38
Jakarta 36
Toronto 36
Yubileyny 36
Ningbo 33
Nuremberg 33
Bremen 32
Düsseldorf 32
Haiphong 32
San Francisco 30
Haikou 29
Mahé 29
Redwood City 29
Wuhan 29
Brooklyn 28
Lanzhou 28
Biên Hòa 27
Hyderabad 27
Paris 27
Hải Dương 25
Orem 25
Totale 31.873
Salva come PNG Salva come JPEG
Nome #
[Angiogenic factors and their relation to stage, lymph-node micrometastases and prognosis in patients operated on for gastric cancer] 1.215
Hepatobiliary Scintigraphy in the Preoperative Evaluation of Potential Living Liver Donors 464
A comprehensive analysis on expected years of life lost due to pancreatic cancer 278
Accuracy of VirtualTouch Acoustic Radiation Force Impulse (ARFI) imaging for the diagnosis of cirrhosis during liver ultrasonography 240
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 238
A new liver transplant priority for patients with hepatocellular carcinoma. 236
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. 230
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 228
Burnout and psychological distress between surgical and non-surgical residents 225
Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis 223
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. 220
Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression. 208
Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study 208
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 204
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 201
The Effect of a Liver Transplant Program on the Outcomes of Resectable Hepatocellular Carcinoma: A Nationwide Multicenter Analysis 199
Combined kidney-liver, heart-liver, and kidney-pancreas transplantations from a single deceased donor. 199
Membrane localization of human equilibrative nucleoside transporter 1 in tumor cells may predict response to adjuvant gemcitabine in resected cholangiocarcinoma patients 198
Bacterial translocation in adult small bowel transplantation 196
Can antiplatelet prophylaxis reduce the incidence of hepatic artery thrombosis after liver transplantation? 196
Combined liver–dual kidney transplant: Role in expanded donors 195
Yttrium-90 microsphere radioembolization in unresectable intrahepatic cholangiocarcinoma 195
BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group. 194
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 194
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. 193
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 192
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 192
Analysis of risk factors for early hepatic artery thrombosis after liver transplantation. Possible contribution of reperfusion in the early morning. 191
Coping strategies in intestinal transplantation 190
Average treatment effect of hepatic resection versus locoregional therapies for hepatocellular carcinoma 190
Assessment of Radiofrequency Ablation Efficacy for Hepatocellular Carcinoma by Histology and Pre-transplant Radiology 190
Italian experience in adult clinical intestinal and multivisceral transplantation: 6 years later. 190
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database 188
Anatomic variations of intrahepatic bile ducts in a European series and meta-analysis of the literature. 187
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma. 187
Abdominal wall transplantation with microsurgical technique 187
Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease. 186
Validation of noninvasive methods for the assessment of liver fibrosis in patients with recurrent hepatitis C after transplantation. 184
Conventional split liver transplantation for two adult recipients: a recent experience in a single European center 183
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatments and outcome. 183
Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension 181
Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patients. 181
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma. 180
Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy? 179
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. 179
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 177
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma 176
Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin 176
Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. 175
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA. database 174
In Reply 171
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period. 171
Pre-transplant psoas muscle density as a ready-to-use and low-cost predictor of patient survival after liver transplant 170
Analysis of cardiovascular, acid-base status, electrolyte and coagulation changes during small bowel transplantation 170
Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers. 170
Contrast-enhanced ultrasonography to diagnose complicated acute cholecystitis 170
Implementation of a patient blood management in an Italian City Hospital: is it effective in reducing the use of red blood cells? 168
Conditional survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. 168
Years of Life Lost for Older Patients After Colorectal Cancer Diagnosis 168
Preliminary results of a "prope" tolerogenic regimen with thymoglobulin pretreatment and hepatitis C virus recurrence in liver transplantation 167
External Validation of Surrogate Indices of Fatty Liver in the General Population: the Bagnacavallo Study 167
Ablation and resection for hepatocellular carcinoma within Milan criteria and high alpha-foetoprotein levels 166
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients 166
A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis. 166
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. 165
null 164
Impact of preoperative infection on outcome after liver transplantation 164
Assessment of long-term prognosis at detection of early hepatocellular carcinoma remains unsolved 163
Incidence, clinical significance, and outcome of vascular alterations in intestinal biopsies after isolated small bowel transplantation: a single-center experience. 163
Clinical outcomes after endoscopic submucosal dissection for colorectal neoplasia: A systematic review and meta-analysis 163
Metabolic disorders across hepatocellular carcinoma in Italy 163
Clinical and molecular determinants of extrahepatic disease progression in patients with metastatic colorectal cancer with liver-limited metastases deemed initially unresectable 163
Post-reperfusion syndrome during isolated intestinal transplantation: outcome and predictors 162
Age and equity in liver transplantation: An organ allocation model. 162
Incidence and management of abdominal closure-related complications in adult intestinal transplantation. 160
Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. 159
Pattern of macrovascular invasion in hepatocellular carcinoma 159
Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study. 158
Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation? 158
Rejection episodes and 3-year graft survival under sirolimus and tacrolimus treatment after adult intestinal transplantation. 157
Critical systematic review on hepatic resection and transarterial chemoembolization for hepatocellular carcinoma 157
Assessment of perioperative transfusion requirement for cirrhotic patients undergoing elective hepatectomy 156
Cost-effectiveness of doxorubicin-eluting beads versus conventional trans-arterial chemo-embolization for hepatocellular carcinoma 156
Comments to “Long-Term Survival Benefit and Potential for Cure After R1 Resection for Colorectal Liver Metastases” 154
Validation of response to yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion 154
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 154
The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation 153
Applying of pretreatment extent of disease system in patients with hepatocellular carcinoma after curative partial hepatectomy 152
Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases. 151
Impact of induction therapy on bacterial infections and long-term outcome in adult intestinal and multivisceral transplantation: a comparison of two different induction protocols: daclizumab vs. alemtuzumab. 151
What is the probability of being too old for salvage transplantation after hepatocellular carcinoma resection? 150
Liver transplantations with donors aged 60 years and above: the low liver damage strategy 149
Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables. 148
Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence. 147
MARS and Prometheus: our clinical experience in acute chronic liver failure. 146
Value of Transient Elastography Measured With Fibroscan in Predicting the Outcome of Hepatic Resection for Hepatocellular Carcinoma. 145
Effect of age on native kidney function after adult intestinal transplants on long-term follow-up 145
Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma 145
Psychological Adaptation and Quality of Life of Adult Intestinal Transplant Recipients: University of Bologna Experience 145
Long-term results after curative resection for carcinoma of the gallbladder according to the TNM stage 144
Totale 19.118
Salva come PNG Salva come JPEG
Categoria #
all - tutte 138.952
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 138.952
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.074 0 0 0 0 0 158 80 226 418 218 196 1.778
2021/20226.222 472 228 353 386 575 297 149 441 259 295 1.855 912
2022/20236.206 633 959 330 736 395 483 212 349 1.106 160 493 350
2023/20241.784 132 303 137 165 154 361 76 108 100 124 63 61
2024/20257.577 351 1.170 671 604 1.149 406 463 208 127 533 332 1.563
2025/20269.850 1.534 1.352 1.638 1.280 1.951 2.095 0 0 0 0 0 0
Totale 47.628